Host–guest complexes of docetaxel, an anti-cancer drug

被引:0
|
作者
T. Lakshmi Kumar
Pooja Guleria
Peddy Vishweshwar
A. Sivalakshmidevi
J. Moses Babu
K. Vyas
Palle V. R. Acharyulu
N. M. Sekhar
B. Selva Kumar
机构
[1] Dr. Reddy’s Laboratories Ltd.,Department of Analytical Research, Discovery Research
[2] Dr. Reddy’s Laboratories Ltd.,Analytical Research and Development, Integrated Product Development
[3] Dr. Reddy’s Laboratories Ltd.,Research & Development, Integrated Product Development
关键词
Anti-cancer drug; Docetaxel; Host–guest complex; Hydrogen bond; Inclusion compound; Supramolecular chemistry;
D O I
暂无
中图分类号
学科分类号
摘要
Host–guest complexes of Docetaxel 1, an anti-cancer drug have been isolated and crystal structures are described. Docetaxel crystallized in the 1:1 molar ratio with n-butanol, dimethylformamide (DMF) and acetonitrile (ACN) during crystallization from the respective solvents. In all the three complexes (1 · n-butanol, 1 · DMF and 1 · ACN), docetaxel formed a host framework through hydrogen bonds and the guest solvent molecules occupied the channels. The host is hydrogen bonded to the guest molecules through hydroxyl moieties. Interestingly, 1 · n-butanol, 1 · DMF and a literature 1 · CH3OH · H2O (1:1:1) host–guest complexes are isomorphs. Further, 1 · ACN complex unit cell parameters are similar (same space group) to the marketed docetaxel trihydrate polymorph (form A).
引用
收藏
页码:261 / 269
页数:8
相关论文
共 50 条
  • [41] Indian anti-cancer drug trials halted
    Sharma, DC
    LANCET, 1999, 353 (9154): : 735 - 735
  • [42] Cannabidiol (CBD) as a Promising Anti-Cancer Drug
    Seltzer, Emily S.
    Watters, Andrea K.
    MacKenzie, Danny
    Granat, Lauren M.
    Zhang, Dong
    CANCERS, 2020, 12 (11) : 1 - 26
  • [43] Anti-Cancer Drug Screening with Microfluidic Technology
    Monjezi, Mojdeh
    Rismanian, Milad
    Jamaati, Hamidreza
    Kashaninejad, Navid
    APPLIED SCIENCES-BASEL, 2021, 11 (20):
  • [44] Bioinformatics Approaches for Anti-cancer Drug Discovery
    Li, Kening
    Du, Yuxin
    Li, Lu
    Wei, Dong-Qing
    CURRENT DRUG TARGETS, 2020, 21 (01) : 3 - 17
  • [45] Exosomes as Drug Carriers in Anti-Cancer Therapy
    Chen, Lan
    Wang, Li
    Zhu, Lingling
    Xu, Zihan
    Liu, Yanyang
    Li, Zhixi
    Zhou, Jin
    Luo, Feng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [46] ROLE OF HEMOPERFUSION IN ANTI-CANCER DRUG REMOVAL
    WINCHESTER, J
    RAHMAN, A
    BREGMAN, H
    MORTENSEN, LM
    GELFAND, MC
    SCHEIN, PS
    SCHREINER, GE
    ARTIFICIAL ORGANS, 1979, 3 (04) : 400 - 400
  • [47] FIRMS BATTLE OVER ANTI-CANCER DRUG
    SUN, M
    SCIENCE, 1983, 222 (4620) : 145 - 145
  • [48] Epigenetic reprogramming in anti-cancer drug resistance
    Tan, Jing
    CANCER SCIENCE, 2024, 115 : 402 - 402
  • [49] Recent Developments in Anti-Cancer Drug Research
    Faisca Phillips, Ana Maria
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (41) : 7282 - 7284
  • [50] Emergencies under drug anti-cancer treatment
    Alig, Annabel
    von Bergwelt, Michael
    Giessen-Jung, Clemens
    ONKOLOGE, 2020, 26 (02): : 120 - 128